To date, the cellular and molecular mechanisms underlying sexual dimorphism in the incidence, prognosis, and treatment responses of cancer remain unclear. In a recent article published in Cancer Cell, Yuan et al. applied a pan-cancer analysis to identify sex-biased molecular signatures and revealed two sex-effect groups characterized by distinct incidence and mortality profiles.
Copyright © 2016 Elsevier Inc. All rights reserved.